GGrantIndex
← Leaderboards

Michael G Carlson

Vanderbilt University

$592
Attributed
$592
Total exposure
6
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$592 · 6

By mechanism

M01$592 · 6

Top collaborators

No co-investigators on record.

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject

Research focus

Human SubjectClinical ResearchExerciseInsulinlike Growth FactorHuman Therapy EvaluationBody WeightDiabetes Mellitus TherapyBody CompositionNoninsulin Dependent Diabetes MellitusInsulin Dependent Diabetes MellitusHomeostasisHormone TherapyHypoglycemiaHypopituitarismInsulinLipid MetabolismLipolysisMedical ComplicationMetabolismMetforminNeuroendocrine SystemObesityPerformancePharmacokinetics

Grant awards (30)

HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2002 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$0
M01 · FY2002 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2002 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2002 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2002 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2002 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2001 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$0
M01 · FY2001 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$0
M01 · FY2001 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$0
M01 · FY2001 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2001 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2001 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2001 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2001 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2001 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2001 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2001 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2001 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2001 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2001 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2001 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2001 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2001 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2001 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$592
M01 · FY2000 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2000 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2000 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2000 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2000 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2000 · RR